New arrivals Administrative Housing Transport Bank and Telephone Taxes Miscellaneous Child care
Honor Roll Alumni
Past Events

First NameRaj
Last NamePuri
Designation/Position/RoleMD., Ph.D.
Institute/OrganisationFDA, Center for Biologics Evaluation and Research
Office Address/LocationDivision of Cellular and gene Therapies, NIH Building 29B, Room 2NN20
WebsiteFDA internet site
ExpertiseRaj K. Puri, M.D., Ph.D. is the Director of the Division of Cellular and Gene Therapies (DCGT) in FDA�s Center for Biologics Evaluation and Research (CBER). He is also a Chief of Tumor Vaccines and Biotechnology Branch in CBER. Dr. Puri oversees the regulation of tumor vaccines, immunotherapy, cellular and gene therapy, tissue engineering, and xenotransplantation products and development of policies and guidance documents in these cutting edge areas of medical research. In addition, Dr. Puri oversees and manages the Critical Path research performed by principle investigators in DCGT to support medical product development. Dr. Puri also directs translational research program in the field of cancer biology/immunology and involved in the application of genomics technology in policy development, outreach, guidance documents and research involving product characterization particularly cancer and embryonic stem cells towards the identification of biomarker of hESC, cancer, cancer stem cells and cancer vaccines. Raj


Blog Postings

India News




Share |